These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 1431024)
1. Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression. Montgomery SA; Rasmussen JG; Lyby K; Connor P; Tanghøj P Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():65-70. PubMed ID: 1431024 [No Abstract] [Full Text] [Related]
2. Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression. Montgomery SA; Rasmussen JG Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():71-3. PubMed ID: 1431025 [No Abstract] [Full Text] [Related]
3. Citalopram in depression--meta-analysis of intended and unintended effects. Bech P; Cialdella P Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():45-54. PubMed ID: 1431021 [TBL] [Abstract][Full Text] [Related]
4. The optimal dosing regimen for citalopram--a meta-analysis of nine placebo-controlled studies. Montgomery SA; Pedersen V; Tanghøj P; Rasmussen C; Rioux P Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():35-40. PubMed ID: 8021436 [TBL] [Abstract][Full Text] [Related]
5. Citalopram and imipramine in the treatment of depressive patients in general practice. A Nordic multicentre clinical study. Rosenberg C; Damsbo N; Fuglum E; Jacobsen LV; Horsgård S Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():41-8. PubMed ID: 8021437 [TBL] [Abstract][Full Text] [Related]
6. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study. Robert P; Montgomery SA Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():29-35. PubMed ID: 7622809 [TBL] [Abstract][Full Text] [Related]
7. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Bech P; Tanghøj P; Andersen HF; Overø K Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396 [TBL] [Abstract][Full Text] [Related]
8. Effective dose of escitalopram in moderate versus severe DSM-IV major depression. Bech P; Andersen HF; Wade A Pharmacopsychiatry; 2006 Jul; 39(4):128-34. PubMed ID: 16871468 [TBL] [Abstract][Full Text] [Related]
10. Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study. Navarro V; Gastó C; Torres X; Marcos T; Pintor L Acta Psychiatr Scand; 2001 Jun; 103(6):435-40. PubMed ID: 11401657 [TBL] [Abstract][Full Text] [Related]
11. Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. Lavretsky H; Kim MD; Kumar A; Reynolds CF J Clin Psychiatry; 2003 Dec; 64(12):1410-4. PubMed ID: 14728100 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial. Guelfi JD; Strub N; Loft H J Affect Disord; 2000 Jun; 58(3):201-9. PubMed ID: 10802128 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression. Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348 [TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with citalopram in patients with highly recurrent forms of unipolar depression. Franchini L; Spagnolo C; Rampoldi R; Zanardi R; Smeraldi E Psychiatry Res; 2001 Dec; 105(1-2):129-33. PubMed ID: 11740983 [TBL] [Abstract][Full Text] [Related]
15. A double-blind double-dummy study of citalopram comparing infusion versus oral administration. Baumann P; Nil R; Bertschy G; Jecker A; Brändli H; Morand J; Kasas A; Vuagniaux O; Ramseier F J Affect Disord; 1998 Jun; 49(3):203-10. PubMed ID: 9629950 [TBL] [Abstract][Full Text] [Related]
16. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial. Singer A; Schmidt M; Hauke W; Stade K Phytomedicine; 2011 Jun; 18(8-9):739-42. PubMed ID: 21514125 [TBL] [Abstract][Full Text] [Related]
17. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study. Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208 [TBL] [Abstract][Full Text] [Related]
18. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792 [TBL] [Abstract][Full Text] [Related]
19. A double-blind placebo-controlled study of Org 3770 in depressed outpatients. Claghorn JL; Lesem MD J Affect Disord; 1995 Jun; 34(3):165-71. PubMed ID: 7560544 [TBL] [Abstract][Full Text] [Related]
20. [Effective treatment of depression following apoplexy with citalopram]. Andersen G; Vestergaard K; Lauritzen LU Ugeskr Laeger; 1995 Apr; 157(14):2000-3. PubMed ID: 7740639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]